InMode Ltd.

General Information
Business:

 

We are a leading global provider of innovative, energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women’s health. We have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling.

Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees: 209
Founded: 2008
Contact Information
Address Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel
Phone Number +972-4-9096313
Web Address http://www.inmodemd.com
View Prospectus: InMode Ltd.
Financial Information
Market Cap $447.6mil
Revenues $109.8 mil (last 12 months)
Net Income $26.1 mil (last 12 months)
IPO Profile
Symbol INMD
Exchange NASDAQ
Shares (millions): 5.0
Price range $14.00 - $14.00
Est. $ Volume $70.0 mil
Manager / Joint Managers Barclays/ UBS Investment Bank/ Canaccord Genuity
CO-Managers Baird
Expected To Trade: 8/8/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change